Moderna Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $163.24 on 04/14/23, while the lowest price for the same duration was marked at $62.55 on 11/02/23.
52-week price history of MRNA Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Moderna Inc’s current trading price is -38.00% away from its 52-week high, while its distance from the 52-week low is 61.81%. The stock’s price range during this period has spanned from $62.55 to $163.24. In the Healthcare sector, the Moderna Inc’s shares surpassed a trading volume of approximately 5.16 million for the day, which was noticeably higher compared to the average daily volume of 9.4.2 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Moderna Inc (MRNA) has experienced a quarterly decline of -10.04% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 38.75B and boasts a workforce of 5600 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 94.01, with a change in price of +27.55. Similarly, Moderna Inc recorded 4,506,775 in trading volume during the last 100 days, posting a change of +37.40%.
Examining MRNA’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for MRNA stands at 0.09. Similarly, the long-term debt-to-equity ratio is also 0.09.
MRNA Stock Stochastic Average
Today, Moderna Inc’s raw stochastic average for the past 50 days stands at 56.81%, indicating a rise from the raw stochastic average of the last 20 days, which was 30.15%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 46.43% and 56.03% respectively.
MRNA Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price gain of 1.77% this year. Over the last six months, there has been a stronger performance of -2.03%. The price of MRNA fallen by 5.43% during the last 30 days period. For the last 5-days stocks have slided -5.77%.
